A bill to require the Comptroller General of the United States to study and report on State Medicaid agencies' options related to the distribution of substance use disorder treatment medications under the Medicaid program.

Assessing Barriers to Opioid Use Disorder Treatment Act This bill requires the Government Accountability Office to report on barriers to the provision of medication used to treat substance use disorders (e.g., buprenorphine) under Medicaid distribution models (e.g., provider purchasing, storage, and administration of medications).